Resources
A wide range of informative monographs, booklets and newsletters; all developed in-house by Cipla.
View allHey there! Welcome!
Get updated on
Select Speciality
Key Trials
Comparison of Tedizolid Phosphate and Linezolid in Treating Acute Bacterial Skin and Skin Structure Infections: The ESTABLISH-1 Trial
ESTABLISH-1 trial was a noninferiority trial of tedizolid phosphate compared to linezolid in treating acute bacterial skin and skin structure infections (ABSSSIs). It concluded that tedizolid phosphate was statistically noninferior to linezolid in early clinical response at 48 to 72 hours after initiating therapy for ABSSSIs.
Spotlight
Slide Library
Allergic Shiners in a Patient with Cough-variant Asthma: A Case Report
A 38-year-old female presented with a persistent cough and a heliotrope rash. She was diagnosed with cough-variant asthma, triggered by antiseptic solutions. Treatment included an empirical asthma trial and avoiding antiseptic exposure. After 2-weeks, her cough resolved, the rash disappeared, and pulmonary function tests improved with no recurrence.
Patient Education
View all
